Name Net reduced
positions
Reduced positions Increased positions Return since
30 Sep ‘19
601
0 5 5 27.5%
602
0 2 2 99.5%
603
0 3 3 83.2%
CMMB
604
Chemomab Therapeutics
CMMB
$11.6M
0 2 2 98.7%
605
0 1 1 97.3%
606
0 2 2 274%
607
0 2 2 97%
608
0 12 12 43.6%
609
0 17 17 56.1%
610
0 1 1 89.6%
DTIL icon
611
Precision BioSciences
DTIL
$111M
0 17 17 98.2%
612
0 1 1 18.3%
613
0 12 12 56.5%
614
0 6 6 73.3%
615
0 1 1 153%
616
0 2 2 11.2%
617
0 1 1 45.8%
618
0 3 3 29.6%
619
0 3 3 11.2%
620
0 5 5 30.8%
621
0 2 2 55.3%
622
0 3 3 95.1%
623
0 4 4 98.3%
624
0 1 1 32.9%
625
0 1 1 50.7%